Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02130401 · ClinicalTrials.gov registry record · NA
Examining the Effects of Neuromodulation on Glucose Metabolism in Type 2 Diabetes
A NA study, sponsored by Scion NeuroStim.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT02130401: Clinical Trial NA study, sponsored by Scion NeuroStim.
NCT02130401 is a NA study that was terminated before completion, run by Scion NeuroStim. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02130401, a NA study, was terminated before completion, sponsored by Scion NeuroStim.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
This is an open-label, proof of concept study with a single active treatment arm designed to assess whether CVS-based stimulation has a beneficial effect on patients with type 2 diabetes. The primary outcome measure is a difference between pre and post-treatment A1c.
Primary Outcome
At the end of the 84 day period of device use, the patient's A1c value will be compared with the baseline value to assess any reduction.
Interventions
- DEVICE TNM Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2014-06 |
| Est. Completion | 2015-06 |
| Phase | NA |
Why NCT02130401 stopped before completion
NCT02130401 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which TNM Device is the first listed.
NCT02130401 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02130401 about?
NCT02130401 is a clinical study titled "Examining the Effects of Neuromodulation on Glucose Metabolism in Type 2 Diabetes". This is an open-label, proof of concept study with a single active treatment arm designed to assess whether CVS-based stimulation has a beneficial effect on patients with type 2 diabetes. The primary outcome measure is a difference between pre and post-treatment A1c.
What is the current status of trial NCT02130401?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2014-06. Estimated completion is 2015-06.
What interventions are being tested in trial NCT02130401?
The interventions under investigation include: TNM Device (DEVICE).
Who is sponsoring clinical trial NCT02130401?
This trial is sponsored by Scion NeuroStim, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02130401's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia